March 8, 2016
Senator Chris Larson Urges Public Hearing on CBD Oil Bill
MADISON – Today, Senator Chris Larson sent a letter to the chair of the Senate Committee on Judiciary and Public Safety urging that a public hearing be held on Senate Bill 772, which would improve access to nonhallucinogenic cannabidiol (CBD) oil. Senator Larson offered the following comments:
“Last session, after hearing many heartbreaking stories from Wisconsin families, legislators from both sides of the aisle worked together to help kids in our state who have rare seizure disorders and may benefit from CBD oil. Compassionate care for Wisconsin children was, and should be, a bipartisan endeavor.
“Unfortunately, it quickly came to the attention of state leaders that there are still significant barriers to accessing CBD oil, and families are desperate for the Legislature to act. That’s why I introduced Senate Bill 772, which would create a process for cannabidiol to be manufactured in the state.
“Senate Bill 772 has been referred to the Senate Committee on Judiciary and Public Safety. Today, I sent a letter to the Committee chair, asking that a public hearing on the bill be scheduled immediately. With the current legislative session rapidly coming to an end, it is imperative that the bill be moved forward quickly, as many Wisconsin families are depending on state legislators to fully remove the barriers stopping children from using this life-changing treatment.
“Last session, we passed a bill that wrote a prescription, but did not provide a way to fill it.”